Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
876,517
-
Share change
-
+111,298
-
Total reported value
-
$70,009,375
-
Put/Call ratio
-
271%
-
Price per share
-
$79.76
-
Number of holders
-
71
-
Value change
-
+$8,992,200
-
Number of buys
-
35
-
Number of sells
-
18
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q1 2022
As of 31 Mar 2022,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
876,517 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, ALTFEST L J & CO INC, Phoenix Holdings Ltd., Orion Portfolio Solutions, LLC, Twelve Points Wealth Management LLC, MORGAN STANLEY, Clough Capital Partners L P, ROYAL BANK OF CANADA, BANK OF AMERICA CORP /DE/, and IMC-Chicago, LLC.
This page lists
73
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.